Author:
Apostolidou Efrosyni,Estey Elihu,Cortes Jorge,Garcia-Manero Guillermo,Faderl Stefan,Thomas Deborah,Tsimberidou Apostolia,Kantarjian Hagop,Giles Francis J.
Subject
Cancer Research,Oncology,Hematology
Reference10 articles.
1. A randomized trial of high-dose vs. standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia;Feldman;Leukemia,1997
2. Gandhi V, Huang P, Xu YZ, et al. Metabolism and action of 2′,2′-difluorodeoxycytidine: self-potentiation of cytotoxicity. Adv Exp Med Biol 1991;125–30.
3. Saturation of 2′,2′-difluorodeoxycytidine-5′-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine;Grunewald;Cancer Chemother. Pharmacol.,1991
4. Pharmacologically directed design of the dose rate and schedule of 2′,2′-difluorodeoxycytidine (gemcitabine) administration in leukemia;Grunewald;Cancer Res.,1990
5. Gemcitabine: a modulator of intracellular nucleotide and deoxynucleotide metabolism;Heinemann;Semin. Oncol.,1995
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献